Skip to main content

Wannan shafin yana aiwatar da ayyuka na asali kuma bai shirya don amfanin marasa lafiya ba tukuna.

Yana aiki

InvVax

Nanoparticle vaccine developer targeting pertussis and P. aeruginosa

Masu kera

Kasa
Czechia
An kafa
Birnin hedikwata
Adireshin hedikwata
Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1RQ, United Kingdom
Imel
Waya

Game da

InvVax develops nanoparticle vaccines targeting pertussis (whooping cough) and Pseudomonas aeruginosa lung infections, utilizing novel antigen display technologies.

Allurar rigakafi

Ba'a sami bayanai ba

Tambayoyi

Ba'a sami tambayoyi ba.